Literature DB >> 4717418

Benzodiazepines and tricyclic antidepressant plasma levels.

G Silverman, R A Braithwaite.   

Abstract

Twelve patients acted successfully as subjects to study what effect if any the benzodiazepines nitrazepam, diazepam, oxazepam, and chlordiazepoxide might have on steady-state plasma levels of nortriptyline and amitriptyline. No significant detectable effect was discovered. In view of the known interaction effects of other alternative tranquillizing drugs and hypnotics it seems reasonable to choose benzodiazepines wherever possible when anxiolytics or hypnotics need to be added during treatment of depression with tricyclic antidepressants.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4717418      PMCID: PMC1587933          DOI: 10.1136/bmj.3.5870.18

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  15 in total

1.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

2.  Plasma concentration of amitriptyline and clinical response.

Authors:  R A Braithwaite; R Goulding; G Theano; J Bailey; A Coppen
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

3.  Plasma levels on antidepressants and clinical response.

Authors:  M Gruvstad
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

4.  Interactions of benzodiazepines with warfarin.

Authors:  M Orme; A Breckenridge; R V Brooks
Journal:  Br Med J       Date:  1972-09-09

5.  Antidepressants and barbiturates.

Authors:  G D Burrows; B Davies
Journal:  Br Med J       Date:  1971-10-09

Review 6.  Drug metabolism and therapeutics.

Authors:  A H Conney
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

7.  A specific gas-chromatographic method for the measurement of "steady-state" plasma levels of amitriptyline and nortriptyline in patients.

Authors:  R A Braithwaite; B Widdop
Journal:  Clin Chim Acta       Date:  1971-12       Impact factor: 3.786

8.  Clinical implications of enzyme induction.

Authors:  A Breckenridge; M Orme
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

9.  Drug metabolism and therapeutics.

Authors:  L F Prescott
Journal:  Scott Med J       Date:  1971-02       Impact factor: 0.729

10.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07
View more
  12 in total

1.  Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Authors:  E Spina; C Gitto; A Avenoso; G M Campo; A P Caputi; E Perucca
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  The significance of drug interactions in the evaluation of psychotropic drugs.

Authors:  R A Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 3.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

4.  Antidepressants in the general hospital.

Authors:  A J Gelenberg
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

5.  The effects of hypnotics on imipramine treatment.

Authors:  B R Ballinger; A Presly; A H Reid; I H Stevenson
Journal:  Psychopharmacologia       Date:  1974

6.  Imipramine: clinical effects and pharmacokinetic variability.

Authors:  N Reisby; L F Gram; P Bech; A Nagy; G O Petersen; J Ortmann; I Ibsen; S J Dencker; O Jacobsen; O Krautwald; I Sondergaard; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

7.  Steady-state kinetics of imipramine in patients.

Authors:  L F Gram; I Sondergaard; J Christiansen; G O Petersen; P Bech; N Reisby; I Ibsen; J Ortmann; A Nagy; S J Dencker; O Jacobsen; O Krautwald
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

8.  Pharmacokinetic aspects of protriptyline plasma levels.

Authors:  J P Moody; S F Whyte; A J MacDonald; G J Naylor
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

9.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.

Authors:  T Cresteil; C Célier; P Kremers; J P Flinois; P Beaune; J P Leroux
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

10.  Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.

Authors:  B Vandel; S Vandel; J M Jounet; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.